Carregant...
Direct-acting Antiviral in the Treatment of Chronic Hepatitis C: Bonuses and Challenges
Owing to the rapid development and wide clinical application of direct acting antiviral (DAA) drugs in the treatment of hepatitis C virus (HCV) infection, the era of interferon-based therapy has almost come to an end. Cumulative studies show that DAA therapy renders high cure efficiency (>90%) an...
Guardat en:
| Publicat a: | Int J Med Sci |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Ivyspring International Publisher
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7163356/ https://ncbi.nlm.nih.gov/pubmed/32308542 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.43079 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|